申请人:Pfizer Limited
公开号:EP0164247A1
公开(公告)日:1985-12-11
Dihydropyridine derivatives of the formula:
and their pharmaceutically acceptable acid addition salts; wherein R is an optionally substituted aryl or heteroaryl group;
R1 and R2 are each independently C,-C. alkyl or 2-methoxyethyl ;
Y is -(CH2)n- where n is 2, 3 or 4 or -CH2CH(CH3)- , and Het is an optionally substituted 5- or 6-membered aromatic heterocyclic group attached to the adjacent oxygen atom by a carbon atom.
The compounds have utility as anti-ischaemic and antihypertensive agents
式中的二氢吡啶衍生物及其药学上可接受的酸加成盐;其中 R 是任选取代的芳基或杂芳基;R1 和 R2 各自独立地为 C,-C.烷基或 2-甲氧基乙基;Y 是-(CH2)n-,其中 n 是 2、3 或 4 或-CH2CH(CH3)-;Het 是任选取代的 5 或 6 元芳香杂环基团,通过一个碳原子连接到相邻的氧原子上。 这些化合物可用作抗缺血和抗高血压药物